W. Xu

ORCID: 0000-0002-0040-0616
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Spondyloarthritis Studies and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Autoimmune and Inflammatory Disorders Research
  • Polysaccharides and Plant Cell Walls
  • Sarcoidosis and Beryllium Toxicity Research
  • Schizophrenia research and treatment
  • Polysaccharides Composition and Applications
  • Bacteriophages and microbial interactions
  • Biofuel production and bioconversion
  • Mental Health and Psychiatry
  • Catalysis for Biomass Conversion
  • Nanoparticle-Based Drug Delivery
  • Bone and Joint Diseases
  • Pharmacological Effects of Natural Compounds
  • Food composition and properties
  • Microbial Metabolites in Food Biotechnology
  • Psoriasis: Treatment and Pathogenesis
  • Lignin and Wood Chemistry
  • Health Systems, Economic Evaluations, Quality of Life
  • Plant Gene Expression Analysis
  • Proteins in Food Systems
  • Scoliosis diagnosis and treatment
  • Attention Deficit Hyperactivity Disorder

Shandong First Medical University
2019-2023

Weifang Medical University
2023

Beijing Forestry University
2019-2023

Linyi University
2023

Fujian University of Traditional Chinese Medicine
2022

Wuhan Polytechnic University
2022

Shandong Provincial QianFoShan Hospital
2019

Shandong University
2019

Janssen (United States)
2013-2016

Northwick Park Hospital
2012

Health-related quality of life in schizophrenia can be assessed by direct patient response or a rating based on structured interview. This study compares both types instruments using series five standards: (1) sensitivity to change over time, (2) treatment effect, (3) correlation with symptom severity, (4) global clinical ratings, and (5) other measures health-related life. Four hundred twenty-three inpatients participating trial comparing clozapine haloperidol (VA Cooperative Study Health...

10.1093/oxfordjournals.schbul.a033484 article EN Schizophrenia Bulletin 2000-01-01

<h3>Objective</h3> To evaluate golimumab9s effect on MRI-detected inflammation and structural damage in patients with active rheumatoid arthritis (RA) despite methotrexate (MTX). <h3>Methods</h3> Patients (n=444) were randomly assigned to placebo plus MTX, golimumab 100 mg placebo, 50 or MTX (subcutaneous injections every 4 weeks). A subset of 240 participated an MRI substudy. MRIs (1.5T+contrast enhancement) the dominant wrist metacarpophalangeal (MCP) joints obtained at baseline weeks 12...

10.1136/ard.2010.146068 article EN Annals of the Rheumatic Diseases 2011-07-21

Introduction: Herein, a hyaluronic acid (HA)-coated redox-sensitive chitosan-based nanoparticle, HA(HECS-ss-OA)/GA, was successfully developed for tumor-specific intracellular rapid delivery of gambogic (GA). Materials and methods: The polymer, HECS-ss-OA, prepared through well-controlled synthesis procedure with satisfactory reproducibility stable resulted surface properties the assembled cationic micelles. GA solubilized into inner core HECS-ss-OA micelles, while HA employed to coat...

10.2147/ijn.s201110 article EN cc-by-nc International Journal of Nanomedicine 2019-06-01

This study compared the time course to clinical improvement with clozapine and conventional antipsychotic medications. A double-blind trial haloperidol in patients schizophrenia who were refractory medication hospitalized for 30 364 days at 15 Veteran Affairs medical centers during year before entry. Patients original randomly assigned or followed 12 months, maximum tolerable doses. completed a full of treatment (n=122), either another (n=123) also 9- 12-month assessment included. Response...

10.1093/oxfordjournals.schbul.a033412 article EN Schizophrenia Bulletin 1999-01-01

<h3>Objectives</h3> Evaluate relationships between MRI and clinical/laboratory/radiographic findings in rheumatoid arthritis (RA). <h3>Methods</h3> 637 methotrexate-naive patients (GO-BEFORE) 444 with active RA despite methotrexate (GO-FORWARD) were randomly assigned to subcutaneous placebo + methotrexate, golimumab 100mg placebo, 50mg or every-4-weeks. In GO-BEFORE(n=318) GO-FORWARD(n=240) substudies, of dominant wrist/metacarpophalangeal joints scored for synovitis, bone oedema erosion (RA...

10.1136/ard.2011.154500 article EN Annals of the Rheumatic Diseases 2011-09-16

Egg-white protein has an abundance of hydrophobic amino acids and could be a potential emulsifier after modification. Here, egg-white was modified via ultrasonic transglutaminase treatments to destroy the globular structure. The gel particles (EWP-GPs) were prepared then novel highly stable EWP-chitosan double-layer emulsion constructed. When treatment applied at 240 W TGase (20 U/g EWP) treatment, EWP-GPs had low particle size good emulsification performance. minimum 287 nm, polymer...

10.3390/molecules27186036 article EN cc-by Molecules 2022-09-16

This study aimed to produce manno-oligosaccharides (MOS) from Gleditsia microphylla galactomannans (GMG) using CO2 and solid acid (Amberlyst-35) in subcritical water. The optimal condition for MOS preparation was 3 MPa CO2, 0.1 g/g (relative GMG) at 150 °C 40 min. maximum yield with a degree of polymerization 2 4 (M2-M4) 52.19%, which doubled the compared either solely or acid. Solid showed excellent performance producing under H2O–CO2 condition, due enhanced mass transfer efficiency...

10.1016/j.lwt.2021.113019 article EN cc-by-nc-nd LWT 2021-12-26

Background: Although GCA is responsive to glucocorticoids (GCS), therapy causes significant toxicity and often fails induce sustained remission. Purpose: Assess safety efficacy of infliximab (IFX) in patients (pts) with new onset a randomized, double-blind, placebo-controlled, multi-center, Phase II study. Methods:Eligibility: diagnosis (ACR criteria); ≤4 weeks (wks) duration; resolution features normal ESR following treatment 40–60 mg prednisone or prednisolone/day; remission for 1 wk prior...

10.1093/rheumatology/keh766 article EN Lara D. Veeken 2005-07-01
Coming Soon ...